Also, STZ-impaired insulin in the brain’s receptors causes alteration of glycogen synthase Kinase (GSK3)9, affecting the activity of GSK3, which is associated with brain disorders such as Alzheimer’s disease, diabetes type 2, and other brain disorders10. This evidence concerns the gene INS and early-onset autosomal dominant Alzheimer disease.